Synthesis of aza mono, bi and tricyclic compounds. Evaluation of their anti MDR activity

European Journal of Medicinal Chemistry

Volumn 38, Issue 1, 2003, Pages 19-26

  Gallo, Sandrine ^a   Atifi, Siham ^a   Mahamoud, Abdallah ^a   Santelli Rouvier, Christiane ^a   Wolfárt, Krisztina ^b   Molnar, Jozsef ^b   Barbe, Jacques ^a  

^a CNRS   (France)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acridinic compounds; P gp inhibitors; Pyridoquinolines

Indexed keywords

ACRIDINE DERIVATIVE; AMINE; PYRIDINE DERIVATIVE; QUINOLINE DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG SCREENING; MULTIDRUG RESISTANCE;

ACRIDINES; ANIMALS; AZA COMPOUNDS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; FLUORESCENT DYES; LEUKEMIA L5178; MICE; MODELS, CHEMICAL; P-GLYCOPROTEIN; PYRIDINES; QUINOLINES; RHODAMINE 123; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037366428     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(02)01422-8     Document Type: Article

References (21)

1. Gottesman M.M., Pastan I. Ann. Rev. Biochem. 62:1993;385-427.
2. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Cancer Res. 41:1981;1967-1972.
3. Seelig A. Eur. J. Biochem. 251:1998;252-261.
4. Klopman G., Leming M.S., Ramu A. Mol. Pharmacol. 52:1997;323-334.
5. Ecker G., Huber M., Schmid D., Chiba P. Mol. Pharmacol. 56:1999;791-796.
6. Hevér A., Santelli-Rouvier C., Brouant P., El Khyari S., Molnar J., Barra Y., Barbe J. Anticancer Res. 18:1998;3053-3058.
7. Surrey A.R., Hammer H.F. J. Am. Chem. Soc. 68:1946;113-116.
8. Breslow D.S., Walker H.G., Yost R.S., Shivers J.C., Hauser C.R. J. Am. Chem. Soc. 68:1946;100-102.
9. Bonse S., Santelli-Rouvier C., Barbe J., Krauth-Siegel R.L. J. Med. Chem. 42:1999;5448-5454.
10. Matias C., Mahamoud A., Barbe J., Pradines B., Doury J.-C. Heterocycles. 43:1996;1621-1632.
11. C. Matias, Ph.D., Marseille, 1997.
12. Lee J., Paull K., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., Bates S.E. Mol. Pharmacol. 46:1994;627-638.
13. Compudrug Chemistry, Ltd, 1994-1995.
14. Chiba P., Ecker G., Schmid D., Drach J., Tell B., Goldenberg S., Gekeler V. Mol. Pharmacol. 49:1996;1122-1130.
15. Morgan R.S., Tatsch C.E., Gushard R.H., McAdon J.M., Warme P.K. Int. J. Peptide Protein Res. 11:1978;209-217.
16. Zauhar R.J., Colbert C.L., Morgan R.S., Welsh W.J. Biopolymers. 53:2000;233-248.
17. Dey S., Ramachandra M., Pastan I., Gottesman M.M., Ambudkar S.V. Proc. Natl. Acad. Sci. USA. 94:1997;10594-10599.
18. Laurence C., Berthelot M. Perspect. Drug Discov. Des. 18:2000;39-60.
19. Berthelot M., Laurence C., Safar M., Besseau F. J. Chem. Soc., Perkin Trans. 2:1998;283-290.
20. Pastan I., Gottesman M.M., Ueda K., Lovelace E., Rutherford A.V., Willingham M.C. Proc. Natl. Acad. Sci. USA. 85:1988;4486-4490.
21. Weaver J.L., Szabo G., Pine P.S., Gottesman M.M., Goldenberg S., Aszalos A. Int. J. Cancer. 54:1993;456-461.